Trading IdeasFundamentals

Dolphin Medical Services Ltd.

BSE: DOLPHMED · Healthcare Service Provider · sector

₹6.78BSE close 2026-10-26

Key numbers

Market cap₹1 cr
Price₹6.78
52w high / low₹10 / ₹2
P/E52.2xSector median 22.9x
P/B0.1xSector median 2.0x
Book value₹62.3
Dividend yield–Sector median 0.55%
ROE0.5%Sector median 5.4%
ROCE0.5%Sector median 6.8%
OPM15.4%Sector median 15.9%
Debt / equity0.09xSector median 0.07x
EV/EBITDA16.2xSector median 17.2x
Interest cover6.0x
Current ratio–
Sales growth 3y+7.1%Sector median +13.5%
Profit growth 3y–Sector median +26.9%
PEG–

Last 12 months to Jun 2026, Standalone. "Sector median" = middle value of 31 companies in Healthcare Service Provider (P/E median leaves out loss-making companies). Tap ? for what a number means.

Things to know

Plain facts from the filings, built by the same fixed rules for every company. A line appears only when the data for it is available. Not a view on the stock.

Charts

Weekly close · high ₹7.17 · low ₹2.00
Sep 2024Apr 2025Mar 2026May 2026

Quarterly results

₹ crMar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue000000
EBITDA-000000
OPM %-28.6%17.6%16.7%19.0%10.5%14.3%
Other income000000
Net profit-000000
EPS (₹)0.050.020.000.010.010.11
Revenue YoY+35.7%+23.5%
Profit YoY–-33.3%

Standalone figures where filed. Latest quarter Jun 2026.

Profit & loss (yearly)

₹ crFY22FY23FY24FY25FY26TTM
Revenue111111
EBITDA-0-0-0000
Net profit-0-0-0-000
EPS (₹)-0.12-0.08-0.070.020.040.13
Revenue growth+17.3%+11.5%+14.7%-3.8%–
Profit growth–––––
Dividend / share (₹)–––––
Compounded growth3 years5 yearsLast 12 months
Sales+7.1%––
Net profit–––
EPS–––
Share price–+73.2% (2y)+212.9%

Balance sheet

₹ crFY25FY26
Shareholders' equity1010
Borrowings11
Cash & equivalents00
Total assets1212
Fixed assets33
Capital work in progress00
Investments00
Receivables00
Inventory00
Payables00

Year-end figures from the March annual filing.

Cash flow

₹ crFY25FY26
Cash from operations-00
Cash from investing0-0
Cash from financing00
Capex00
Free cash flow-0-0

Free cash flow = cash from operations − capex.

Ratios by year

₹ crFY25FY26
ROE %-0.3%0.4%
ROCE %-0.2%0.6%
Debtor days00
Inventory days3034
Payable days00
Cash conversion cycle (days)3034
Working capital days656959

Peers in Healthcare Service Provider

CompanyMarket capP/EP/BROEROCEOPMSales 3yDiv yield
LALPATHLAB₹31,100 cr57.2x12.4x23.1%29.6%27.9%+11.1%0.71%
VIJAYA₹14,362 cr76.6x15.0x21.4%30.1%42.2%+21.0%0.14%
METROPOLIS₹10,989 cr54.5x7.3x14.2%19.7%24.2%+12.8%0.19%
THYROCARE₹7,491 cr42.6x12.8x31.1%39.7%31.4%+16.3%1.99%
NEPHROPLUS₹6,095 cr71.6x5.5x6.9%13.4%22.7%––
SURAKSHA₹1,628 cr45.4x6.7x15.7%25.2%31.4%––
KRSNAA₹1,617 cr16.6x1.6x10.5%11.1%26.8%+16.6%0.55%
3BBLACKBIO₹1,193 cr21.2x3.7x18.7%22.8%34.9%+127.8%0.29%
HEALTHX₹857 cr–3.2x-0.5%––––
DOLPHMED₹1 cr52.2x0.1x0.5%0.5%15.4%+7.1%–

All 31 companies in Healthcare Service Provider →

Documents

Links go to the original files on the exchange website.

About the company

SectorHealthcare
IndustryHealthcare Service Provider
Sub-industryHealthcare Service Provider
SymbolDOLPHMED
BSE code526504
ISININE796B01013
Face value₹10.0
Incorporated–
Website–
Plants (India / abroad)–

Data built 2026-10-24 from BSE company filings (inline XBRL: Integrated Filing - Finance) + BSE results summary for earlier years; price = BSE close 2026-10-26.